© Pint of Science, 2025. All rights reserved.
Lymphocytes are key players within our immune system but transformation of these cells into a cancerous state poses a major threat. Join us to find out how Dr Hodson and his team are working to bring new insights into the process! Dr Jessica Taylor will be discussing her research in designing novel diagnostic and therapeutic probes for children with medulloblastoma, the most common brain tumour in children. Her focus is on changing the way we treat cancer, with a particular emphasis on children with WNT-medulloblastoma.
From DNA to treatment in Blood cancer
Dr Dan Hodson
(Group Leader, Department of Haematology, University of Cambridge)
Non-Hodgkin lymphoma is a common form of blood cancer. It arises from the cancerous transformation of immune system cells called lymphocytes. New technologies reveal the complex and multiple routes that transform a normal lymphocyte into cancerous lymphoma.By recreating these steps in the laboratory, we can uncover the biological pathways upon which lymphomas depend and reveal the potential for biologically directed, “precision medicine” approaches to cure lymphoma.
Understanding Medullablastomas
Dr Jessica Taylor
(Research Fellow at Emmanuel College, University of Cambridge)
Dr Jessica Taylor's research focuses on Medullablastoma, the most common malignant brain tumour in children. WNT-medulloblastoma, a subgroup, has a 5-year survival rate of ~90%; however, this cure comes at enormous cost to the child. The aggressive surgery, radiotherapy, and chemotherapy can cause long-term side effects that can devastate each survivor’s quality of life. Join us to find out how her research aims to design novel tumour-specific probes which will allow us to not only treat these children in a less harmful way, but to diagnose these tumours non-invasively.
Map data © OpenStreetMap contributors.